BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24313309)

  • 1. Delayed post-operative haemorrhage after carmustine wafer implantation: a case series from two UK centres.
    Shah RS; Homapour B; Casselden E; Barr JG; Grundy PL; Brydon HL
    Br J Neurosurg; 2014 Aug; 28(4):488-94. PubMed ID: 24313309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.
    Barr JG; Grundy PL
    Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation.
    Chaichana KL; Kone L; Bettegowda C; Weingart JD; Olivi A; Lim M; Quinones-Hinojosa A; Gallia GL; Brem H
    Neurol Res; 2015 Aug; 37(8):717-26. PubMed ID: 25916669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
    Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
    Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J
    J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
    Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
    Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.
    Subach BR; Witham TF; Kondziolka D; Lunsford LD; Bozik M; Schiff D
    Neurosurgery; 1999 Jul; 45(1):17-22; discussion 22-3. PubMed ID: 10414561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.
    Dyke JP; Sanelli PC; Voss HU; Serventi JV; Stieg PE; Schwartz TH; Ballon D; Shungu DC; Pannullo SC
    J Neurooncol; 2007 Mar; 82(1):103-10. PubMed ID: 17031552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.
    Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A
    J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
    Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
    J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis.
    Mu F; Lucas JT; Watts JM; Johnson AJ; Daniel Bourland J; Laxton AW; Chan MD; Tatter SB
    J Clin Neurosci; 2015 Mar; 22(3):561-5. PubMed ID: 25560387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
    J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
    Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
    J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
    Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.
    Pallud J; Audureau E; Noel G; Corns R; Lechapt-Zalcman E; Duntze J; Pavlov V; Guyotat J; Hieu PD; Le Reste PJ; Faillot T; Litre CF; Desse N; Petit A; Emery E; Voirin J; Peltier J; Caire F; Vignes JR; Barat JL; Langlois O; Dezamis E; Parraga E; Zanello M; Nader E; Lefranc M; Bauchet L; Devaux B; Menei P; Metellus P;
    Neuro Oncol; 2015 Dec; 17(12):1609-19. PubMed ID: 26185110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice.
    Price SJ; Whittle IR; Ashkan K; Grundy P; Cruickshank G;
    Br J Neurosurg; 2012 Jun; 26(3):331-5. PubMed ID: 22482926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    Sage W; Guilfoyle M; Luney C; Young A; Sinha R; Sgubin D; McAbee JH; Ma R; Jefferies S; Jena R; Harris F; Allinson K; Matys T; Qian W; Santarius T; Price S; Watts C
    J Neurooncol; 2018 Jan; 136(2):273-280. PubMed ID: 29139095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.